DigiBiomics

About

DigiBiomics Inc is a Canadian health-tech startup based in Mississauga, specializing in AI-powered precision diagnostics for early disease detection and personalized patient care. Founded in 2021, the company aims to enhance early disease detection and reduce misdiagnosis through advanced data-driven solutions. The flagship product, LungSense, is an AI-driven diagnostic platform that accurately detects lung diseases at an early stage. It integrates various data sources, including X-rays, HRCT scans, clinical data, and cough sound analysis. DigiBiomics also develops PulmoDeep, another diagnostic solution focused on respiratory health. The company utilizes digital twin technology as part of its innovative diagnostic approach. Meraj Khan, the CEO and founder, brings expertise in precision diagnostics and clinical research to the team.